EyePoint Pharmaceuticals
EYPT
$19.74
Share price
-1.00%
Change (1 day)
201.83%
Change (1 year)
Categories
Earnings for EyePoint Pharmaceuticals (EYPT)
Earnings in 2023 (TTM): -$69.47 M
According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$69.47 M. an increase over its 2022 earnings that were of -$99.07 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for EyePoint Pharmaceuticals from 2003 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | -$69.47 M | -29.88% |
| 2022 | -$99.07 M | 87.2% |
| 2021 | -$52.92 M | 38.58% |
| 2020 | -$38.19 M | -24.56% |
| 2019 | -$50.62 M | |
| 2017 | -$23.09 M | 22.59% |
| 2016 | -$18.84 M | -8.02% |
| 2015 | -$20.48 M | -296.09% |
| 2014 | $10.44 M | -174.02% |
| 2013 | -$14.11 M | 37.42% |
| 2012 | -$10.27 M | -56.29% |
| 2011 | -$23.49 M | -1062.38% |
| 2010 | $2.44 M | -250.43% |
| 2009 | -$1.63 M | -89.5% |
| 2008 | -$15.46 M | |
| 2005 | -$9.53 M | 56.99% |
| 2004 | -$6.07 M | 73.7% |
| 2003 | -$3.5 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$2.17 M | -96.89% | Bahamas |
 NRC Health
NRC | $40.82 M | -158.77% | 🇺🇸 USA |